(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 8.35% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.3%.
Tilray Brands's revenue in 2026 is $963,100,000.On average, 14 Wall Street analysts forecast TLRY's revenue for 2027 to be $166,260,963,375, with the lowest TLRY revenue forecast at $154,437,961,535, and the highest TLRY revenue forecast at $175,867,152,370. On average, 12 Wall Street analysts forecast TLRY's revenue for 2028 to be $176,014,939,893, with the lowest TLRY revenue forecast at $164,191,938,053, and the highest TLRY revenue forecast at $186,064,491,457.
In 2029, TLRY is forecast to generate $179,118,477,876 in revenue, with the lowest revenue forecast at $159,610,524,840 and the highest revenue forecast at $194,931,742,837.